These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21113605)

  • 21. Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs.
    Yap YG; Camm AJ
    Am J Cardiol; 1999 Nov; 84(9A):83R-89R. PubMed ID: 10568665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flecainide acetate for the treatment of atrial and ventricular arrhythmias.
    Apostolakis S; Oeff M; Tebbe U; Fabritz L; Breithardt G; Kirchhof P
    Expert Opin Pharmacother; 2013 Feb; 14(3):347-57. PubMed ID: 23294160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Beta blockers in arrhythmias].
    Fuhrer J
    Praxis (Bern 1994); 1995 Mar; 84(11):304-12. PubMed ID: 7724946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amiodarone: the expanding antiarrhythmic role and how to follow a patient on chronic therapy.
    Singh BN
    Clin Cardiol; 1997 Jul; 20(7):608-18. PubMed ID: 9220176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Magnesium: current studies--critical evaluation--consequences].
    Meinertz T
    Z Kardiol; 1996; 85 Suppl 6():147-51. PubMed ID: 9064959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with propafenone for cardiac arrhythmias in the young.
    Heusch A; Kramer HH; Krogmann ON; Rammos S; Bourgeous M
    Eur Heart J; 1994 Aug; 15(8):1050-6. PubMed ID: 7527342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiology of beta blockers in supraventricular arrhythmias.
    Kowey PR; Friehling TD; Marinchak RA
    Am J Cardiol; 1987 Aug; 60(6):32D-38D. PubMed ID: 2888299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in the pharmacologic treatment of ventricular arrhythmias.
    Schleifer JW; Sorajja D; Shen WK
    Expert Opin Pharmacother; 2015; 16(17):2637-51. PubMed ID: 26513538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects].
    Steinbeck G
    Z Kardiol; 1992; 81 Suppl 4():139-43. PubMed ID: 1290290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
    Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous magnesium for the treatment of cardiac arrhythmias.
    Arnold DJ
    Aust N Z J Med; 2000 Feb; 30(1):54-60. PubMed ID: 10800879
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.
    Rae AP
    Am J Cardiol; 1998 Oct; 82(8A):59N-65N. PubMed ID: 9809902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic properties of beta-blockers.
    Haverkamp W; Hindricks G; Gülker H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S29-32. PubMed ID: 11527133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of almokalant, a class III antiarrhythmic agent, on supraventricular, reentrant tachycardias. Almokalant Paroxysmal Supraventricular Tachycardia Study Group.
    Darpö B; Edvardsson N
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):499-508. PubMed ID: 9310280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A benefit-risk assessment of class III antiarrhythmic agents.
    Brendorp B; Pedersen O; Torp-Pedersen C; Sahebzadah N; Køber L
    Drug Saf; 2002; 25(12):847-65. PubMed ID: 12241126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance and control of cardiac arrhythmias in patients with congestive cardiac failure.
    Singh BN
    Heart Fail Rev; 2002 Jul; 7(3):285-300. PubMed ID: 12215733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sotalol: An important new antiarrhythmic.
    Anderson JL; Prystowsky EN
    Am Heart J; 1999 Mar; 137(3):388-409. PubMed ID: 10047618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.